• WCG’s eCOA portfolio and imaging analysis technology from NeuroRx are now part of Clario!

menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • Study Endpoints
        • Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world.

        • Collect continuous ECG data in site-based or hybrid trials with our flexible solutions and patient-friendly devices.

        • Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to hybrid trials.

        • Monitor every heartbeat with precision to assess safety and efficacy throughout your site-based or hybrid clinical trial.

        • Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial.

        • Leverage our key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

        • Make your clinical trials easier, faster, more engaging and accessible to all.

        • Enjoy flexible, fast and confidential site assessments at home.

        • Enhance your ePRO data with photo and audio capture.

        • Accelerate your clinical trial setup with Clario’s pre-validated and configured eCOA assessments.

        • Improve data accuracy and reduce variability in scoring with Clario’s training solutions.

        • Your trusted partner for the richest eCOA endpoint data in your clinical trial.

        • Monitor Suicide Ideation and Behavior (SIB) in clinical trials effectively with Clario’s suicide assessment tool, eC-SSRS.

        • Accelerate drug development and reduce risk with Clario’s comprehensive medical imaging core lab services.

        • The Clario team includes medical imaging experts and globally recognized key opinion leaders (KOLs) representing multiple disciplines.

        • Clario’s Image Redact AI automatically redacts sensitive patient identifiers from videos, photos and PDFs.

        • Secure accurate results, streamline your processes, and meet your unique needs with our imaging platform.

        • Leverage our full range of medical imaging and diagnostic imaging modalities, including CT Scans, Endoscopy, MRIs, and more.

        • Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards.

        • Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

        • The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights.

        • Explore more than 750 scientific publications that reflect the technical and clinical applications of Clario’s Opal® System.

        • Everything you need for high quality, low variability pulmonary function data and high patient compliance for clinical trials.

        • Centralized, on-site pulmonary function testing for clinical trials.

        • Remote spirometry testing for respiratory clinical trials.

        • Assess cough frequency, cough severity and other lung sounds such as crackles or rhonchi for clinical trials.

        • Assess the capacity of the lungs for effective gas transfer.

        • Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data.

        • Collect, centralize and manage participant screening and eligibility data with customized workflows.

        • Boost stakeholder insights with business intelligence (BI) tools, analytics for endpoint and safety risks, and data exchange solutions.

        • Securely collect, store and share compliant images in the cloud to keep clinical trial sponsors and labs informed.

    • Segments
    • Study Phases
    • Technology
  • Therapeutic Areas
    • Cardiovascular & Metabolic Icon RGBCardiovascular & Metabolic
    • Dermatology Icon RGBDermatology
    • Type 2 Diabetes and Obesity iconDiabetes and Obesity
    • Gastroenterology Icon RGBGastroenterology
    • Hepatology Icon RGBHepatology
    • Infectious Disease Icon RGBInfectious Diseases
    • Muskoskeletal Icon RGBMusculoskeletal
    • Neuroscience Icon RGBNeuroscience
      • Neuroscience Indications
    • Oncology Icon RGBOncology
    • Ophthalmology Icon RGBOphthalmology
    • Respiratory Solutions IconRespiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rapid Start
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)
    • Cardiac Solutions
      • Cardiac Solutions
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Imaging Platform
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion for Clinical Trials
      • Precision Motion for Research
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, and more.)
      • Virtual Home Spirometry
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Hybrid Trials
    • Biotechs
    • CROs
    • Pharma
    • Phase I
    • Phase II/III
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology
    • Ophthalmology
    • Type 2 Diabetes and Obesity
    • Respiratory Solutions
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home Resources Blog Articles Ensuring data quality in home spirometry

Ensuring data quality in home spirometry

Best practices and key considerations with remote spirometry testing

Dr. Kai Michael Beeh – Pulmonary Medical Scientific Expert

It is no secret that decentralized trials (DCTs) have gained acceptance within our industry since the onset of COVID-19 for both patients and clinicians. According to a December 2020 survey by McKinsey, 100% of pharma and CROs expected virtual trials to be a significant component of their portfolios, up from 38% in December 2019.1 With so many partners to choose from, how do pharmaceutical companies decide which is right for them? 

The answer to this is not as easy as choosing between orange, purple and green; it’s selecting the best option on a scale with ten different hues of gray, making Clario the only company capable of distinguishing among them. This article focuses on best practices and key considerations with remote spirometry testing by sharing three critical success factors to consider when selecting a sponsor for your trials.

Achieving data quality

As clinical trial technology evolves, it provides more opportunities to gather end point data in a variety of hybrid and fully decentralized trials, but this cannot be at the expense of the data quality. For instance, during a pulmonary function test, the patient must exert maximum effort to achieve quality results. The nurse observes the patient to ensure accurate data collection when conducted on-site. This procedure is challenging even when performed on-site. It becomes increasingly difficult when the patient performs the assessment at home without active coaching. 

To reduce or eliminate any discrepancies in data quality, whether a patient is performing the pulmonary function test at the clinic or home, Clario developed iSpiro, a highly accurate, user-friendly decentralized spirometry solution. In 2021, Clario launched iSpiro Virtual Visits to connect the patient and nurse via video for remote coaching and expert guidance for the patients to ensure high-quality endpoint data is collected by the patient whether they are located at the site or at home.

Minimizing patient burden and cost

When it comes to home spirometry testing, patient experience must be top of mind. Pulmonary function testing should be as effective as possible to minimize the number of attempts by the patient and ensure the highest data quality is captured. In DCTs, patients often take on the role of the nurse. This can create greater challenges with patients being remote, leading to increased variability. The better we can mitigate the factors to reduce variability by educating and coaching the patient during the process with real-time remote coaching and virtual visits for patient guidance, the better the outcome for all involved.

For companies that perform fewer clinical trials, this is a daunting task. At Clario, we have experience and success in every clinical setting imaginable. With recent dynamic advancements in data collection, Clario provides unique technologies to obtain FEV1/FVC data from patients at home or under supervision by site personnel via remote transmission of data and video.

Ensuring patient safety

In conducting home spirometry testing, a patient’s safety is paramount. Safety concerns can quickly be treated on-site in a traditional clinical trials setting. However, at home, we must consider possibilities that could arise during the assessment – whether or not that concern is the direct result of the evaluation. Thus, connecting the nurse and patient for real-time observation and step-by-step instructions is essential to ensure the measurements’ quality, safeguard the patient’s safety, and mitigate any risks to their health or a company’s liability. Critical instructions could be as simple as ensuring the patient is sitting down.

As the clinical trials ecosystem rapidly evolves, the need for safe and reliable remote data collection is increasing. With iSpiro Virtual Visits, Clario delivers customer and patient-oriented innovations that facilitate decentralization.

On February 24, 2022, Clario will host a webinar where Clario respiratory experts and Dr. Kai Beeh will discuss challenges in ensuring data quality when not supported and coached virtually by experienced site personnel. Register for the webinar to learn more.

Revolutionizing respiratory assessments from comfort of home

Seeking a flexible approach to spirometry? Clario introduces home hybrid DCT spirometry solutions, blending reliability with the convenience of at-home assessments.

Learn more

References:

1https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/no-place-like-home-stepping-up-the-decentralization-of-clinical-trials

Back to articles
Share
Twitter Facebook LinkedIn

Latest articles

See all articles
Article

Researcher spotlight: Dr. Lauren Tueth

Precision Motion

Read
Article

Researcher spotlight: Brice Cleland

Precision Motion

Read
Article

Researcher spotlight: Josefa Domingos

Precision Motion

Read
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.


Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2025 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum